Recruiting

Observational StudyHPV Prevalence in 16-20 Year Old Males

Sponsor:

Laval University

Code:

NCT04297670

Conditions

HPV Infection

Eligibility Criteria

Sex: Male

Age: 16 - 20

Healthy Volunteers: Accepted

Interventions

Measurement of HPV types prevalence

Study Details

Brief summary:

In Quebec, 18 birth cohorts of girls were vaccinated against HPV (aged 9 to 29 years in 2020). With an observed vaccination coverage of >80% an important herd effect might be expected. This study aim is to measure the HPV types prevalence in unvaccinated sexually active boys aged 16 to 20 years.

Conditions

HPV Infection

Study ID

NCT04297670

Start date

Feb 20, 2020

Status verified date

Mar, 2020

Completion date

Dec 31, 2020

Anticipated

Primary completion date

Dec 31, 2020

Anticipated

Eligibility Criteria

Sex: Male

Age: 16 - 20

Healthy Volunteers: Accepted

Inclusion Criteria:

unvaccinated against HPV
sexually active

Exclusion Criteria:

received an HPV vaccine
non sexually active

Study Design

Enrollment

681 participants

Anticipated

Interventions and Outcome Measures

Arms

Unvaccinated against HPV boys

Sexually active unvaccinated against HPV 16-20 years old boys.

Interventions

Measurement of HPV types prevalence

Self collected genital samples to be tested for the presence of different HPV types.

Primary outcome measure

Prevalence of HPV 6/11/16/18/31/33/45/52 and 58 [ Time Frame: Up to 18 months ]

Central Contacts and Locations

Central contacts

Chantal Sauvageau, MD, MSc

1 418 650 5115 chantal.sauvageau@inspq.qc.ca

Vladimir Gilca, MD, PhD

1 418 650 5115 vladimir.gilca@inspq.qc.ca

Locations

Laval University Research Hospital Center

Recruiting

Quebec, Canada, G1E7G9

Contacts

Chanta Sauvageau, MD, MSc

418 650 5115 chantal.sauvageau@inspq.qc.ca

Vladimir Gilca, MD, PhD

4186667000 vladimir.gilca@inspq.qc.ca

Principal Investigator:

Chantal Sauvageau, MD, MSc

More Information

Sponsor

Laval University

Last update posted

Mar 5, 2020

Last verified

Mar, 2020

Keywords

Prevalence
Boys

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Laval University on 2020-03-05.